Plaque Psoriasis | The Truth About Skin Care

{ Tag Archives } Plaque Psoriasis

STELARA® Three-Year Efficacy And Safety Data Presented On Patients With Moderate To Severe Plaque Psoriasis

Main Category: Dermatology
Also Included In: Clinical Trials / Drug Trials; Pharma Industry / Biotech Industry
Article Date: 10 Aug 2010 – 1:00 PDT

email to a friend printer friendly view / write opinions
<!– rate article

New study findings showed that a majority of patients with moderate to severe plaque psoriasis who had [...]

Also tagged Academy Of Dermatology, American Academy Of Dermatology, Biotech Industry, Clinical Response, Efficacy, Friendly View, Mg Doses, Phase 2, Phase 3, Psoriasis, Psoriasis Area And Severity Index, Rate Article, Risk Profile, Safety Analysis, Safety Data, Severe Plaque Psoriasis, Study Findings, Study Patients, Summer Academy

2010 08 10 Skin Care News Comments Off

STELARA(TM) Shows Greater Efficacy Than Etanercept For Treatment Of Moderate To Severe Plaque Psoriasis

Findings from an international, Phase 3 clinical study comparing the efficacy and safety of STELARA™ (ustekinumab) with etanercept (Enbrel®) in the treatment of moderate to severe plaque psoriasis appear in The New England Journal of Medicine. The results showed a significantly higher clinical response with both doses of STELARA than with etanercept over a 12-week [...]

Also tagged Clinical Response, Efficacy, Enbrel, England Journal Of Medicine, Etanercept, International Phase, Journal Of Medicine, Medicine, New England, New England Journal, New England Journal Of Medicine, New Medicine, Phase 3, Psoriasis

2010 01 15 Skin Care News Comments Off

Provectus Reaches Milestone With Completion Of Patient Accrual In Phase 2 Trial Of PH-10 For Psoriasis

Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development stage oncology and dermatology biopharmaceutical company, has completed patient accrual and initial treatment in its Phase 2 trial of PH-10 for the treatment of plaque psoriasis. This milestone marks the third Phase 2 clinical trial for which Provectus has completed patient accrual since May 2009.

Also tagged Accrual, Biopharmaceutical Company, Clinical Trial, Development Stage, Initial Treatment, Milestone, Oncology, Otc Bb, Pharmaceuticals Inc, Phase 10, Phase 2, Provectus Pharmaceuticals, Psoriasis

2009 10 15 Skin Care News Comments Off

FDA Approves New Drug To Treat Psoriasis

The U.S. Food and Drug Administration approved Stelara (ustekinumab), a biologic product for adults who have a moderate to severe form of psoriasis. Plaque psoriasis is an immune system disorder that results in the rapid overproduction of skin cells. About 6 million people in the United States have plaque psoriasis which is characterized [...]

Also tagged 6 Million, Adults, Fda, Food And Drug, Food And Drug Administration, Immune System Disorder, Overproduction, Patches, Psoriasis, Red Skin, Silvery Scales, Skin Cells, United States

2009 09 28 Skin Care News Comments Off

FDA Extends Review Timeline For STELARA(TM) (ustekinumab) Biologic License Application By Three Months

Centocor Ortho Biotech Inc. announced that the U.S. Food and Drug Administration (FDA) has extended by three months the review timeline for the Biologic License Application (BLA) for STELARA(TM) (ustekinumab) to provide time for a full review of an amendment to the pending application. The application seeks approval to market STELARA for the treatment of [...]

Also tagged Adult Patients, Bla, Fda, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, License Application, Psoriasis, Severe Plaque Psoriasis, Systemic Therapy, Three Months, Timeline

2009 05 27 Skin Care News Comments Off

Topical Treatments For Chronic Plaque Psoriasis

Chronic plaque psoriasis is the most common type of psoriasis and is characterised by redness, thickness and scaling. First line management of chronic plaque psoriasis is with topical treatments, including vitamin D analogues, topical corticosteroids, tar-based preparations, dithranol, salicylic acid and topical retinoids.

Also tagged Analogues, Chronic Plaque Psoriasis, Line Management, Psoriasis, Psoriasis Treatments, Salicylic Acid, Tar, Topical Corticosteroids, Topical Retinoids, Topical Treatments, Vitamin D

2009 04 16 Skin Care News Comments Off

BioCis Pharma Starts Phase IIa Trial In Psoriasis

BioCis Pharma Ltd., a privately-held drug development company with its headquarters in Turku, Finland, announced that it has begun a new Phase IIa clinical testing of ProtoCure(TM) emulsion cream, the company’s novel topical drug for dermatology. The double-blind, vehicle-controlled study is designed to evaluate the tolerability, pharmacokinetics, and efficacy of the topical product in a [...]

Also tagged Drug Development Company, Efficacy, Emulsion, Pharma Ltd, Pharmacokinetics, Phase Iia, Psoriasis, Topical Drug, Turku Finland

2009 03 13 Skin Care News Comments Off

Galderma Announces Interim Data Relating To Sequential Treatment Regimen Of Clobex(R) Spray Followed By Vectical(TM) Ointment In Managing Psoriasis

Galderma Laboratories, L.P. announced interim findings from a study of sequential treatment of plaque psoriasis using Clobex(R) (clobetasol propionate) Spray 0.05% followed by treatment with Vectical(TM) (calcitriol) Ointment 3mcg/g. The results of an interim analysis of the data are to be presented in a poster session at the 67th Annual Meeting of the American Academy [...]

Also tagged Academy Of Dermatology, American Academy Of Dermatology, Annual Meeting, Clobetasol Propionate, Galderma Laboratories, Interim Analysis, Interim Data, Interim Findings, Poster Session, Psoriasis, Reference Number, Treatment Regimen

2009 03 07 Skin Care News Comments Off

The Truth About Skin Care

{ Tag Archives } Plaque Psoriasis

STELARA® Three-Year Efficacy And Safety Data Presented On Patients With Moderate To Severe Plaque Psoriasis

STELARA(TM) Shows Greater Efficacy Than Etanercept For Treatment Of Moderate To Severe Plaque Psoriasis

Provectus Reaches Milestone With Completion Of Patient Accrual In Phase 2 Trial Of PH-10 For Psoriasis

FDA Approves New Drug To Treat Psoriasis

FDA Extends Review Timeline For STELARA(TM) (ustekinumab) Biologic License Application By Three Months

Topical Treatments For Chronic Plaque Psoriasis

BioCis Pharma Starts Phase IIa Trial In Psoriasis

Galderma Announces Interim Data Relating To Sequential Treatment Regimen Of Clobex(R) Spray Followed By Vectical(TM) Ointment In Managing Psoriasis

Home

Recommendations

Free Ebook

Latest News

Site Features

Get a free ebook valued at $8.95 when you sign up for our free Skincare Tips newsletter. The book The Truth About Skincare: How To Have Younger Looking Skin sells every day for $8.95 at Bargain Books Web. It's yours at no cost by immediate download when you sign up right now. You can unsubscribe any time, and the book is yours to keep.
Name:
Email: